"10.1371_journal.pone.0058258","plos one","2013-03-06T00:00:00Z","Hsi-Min Hsiao; Ramil E Sapinoro; Thomas H Thatcher; Amanda Croasdell; Elizabeth P Levy; Robert A Fulton; Keith C Olsen; Stephen J Pollock; Charles N Serhan; Richard P Phipps; Patricia J Sime","Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, New York, United States of America; Lung Biology and Disease Program, University of Rochester, Rochester, New York, United States of America; Division of Pulmonary and Critical Care Medicine, University of Rochester, Rochester, New York, United States of America; Department of Environmental Medicine, University of Rochester, Rochester, New York, United States of America; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women’s Hospital, Harvard Institutes of Medicine and Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: HH RS TT AC CS RP PS. Performed the experiments: HH RS RF EL KO AC SP. Analyzed the data: HH RS TT AC CS RP PS. Wrote the paper: HH RS TT CS RP PS.","TT is a PLOS One Editorial Board Member. CS is an inventor on patents [resolvins] assigned to BWH and licensed to Resolvyx Pharmaceuticals. CS is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. CNS’s interests were reviewed and are managed by the Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. No other authors have competing interests to declare.","2013","03","Hsi-Min Hsiao","HMH",11,TRUE,7,7,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
